1. Market Research
  2. > Pharmaceutical

Pharmaceutical Market Research: Pharma Industry Analysis Reports

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
109 votes

Global Pharmaceutical Industry Overview

The pharmaceutical industry consists of companies involved in the research, development and marketing of drugs and biologics.

The pharmaceutical market was driven by a rise in healthcare spending and high growth in both emerging markets and the biologics segment. Cancer is the largest segment. This was closely followed by the pain and diabetes segments with shares of 6% and 5% respectively, according to IMS.

Key Pharmaceutical International Markets

  • North America is the largest market, with revenues exceeding $340 billion.
  • This was followed by Europe with revenues of $224 billion according to IMS.
  • Emerging countries in Asia and Latin America are forecast to grow rapidly. Increase in spending in these countries will be driven by rising incidence of disease, favorable government policies and improving healthcare infrastructure (and the multiplication of drug stores and pharmacies in large cities.

Pharmaceutical Industry Key Players

Novartis is the pharmaceutical market leader (thanks to a state-of-the-art drug discovery and development department) with revenues of $51 billion and a market share of 5%. Primary contributors to its sales were the drugs Gilenya and Affinitor. Pfizer is close behind Novartis with a 4% share of the global market according to IMS.

The top ten players are forecast to collectively lose share from 35% in 2013 to 30% in 2017, according to IMS. Patent expiries over the next few years will eat into the revenues of most companies during this period.

Sanofi potential loss due to patent expiries is estimated to reach up to $8.1 billion. The company is then followed by Novartis, Roche, Astra-Zeneca and Eli Lilly with respectively potential losses of 7.7, 7.2, 6.7 and 6 billion dollars.  

Pharmaceutical Market Sales Forecast 

Pharmaceutical industry trends show that the global market is set to show steady growth in the next five years at a CAGR of 4-5%. Innovative on-prescritpion drugs and over-the-counter drugs entering the market and biologics such as targeted therapies for cancer will be key in driving growth.

Key Trends and Strategies for Growth in the Pharmaceutical Market

Four trends are shaping pharmaceutical markets.

New Government Policies are Expanding Healthcare Coverage

Expanded patient coverage is a key trend in the pharmaceutical market. China has increased its healthcare spending to $116 billion as part of its latest 12 year plan. India has created a $5 billion policy aimed at providing health services to government hospitals and clinics, especially in the rural areas. The U.S. Affordable Care Act and the U.K. Health and Social Care Act also create opportunities.

The differing nature of the policies means pharmaceutical companies must adapt their marketing strategies for each region or country. A ‘one size fits all’ strategy will no longer work.

Emerging Pharmaceutical Markets are Improving Healthcare Provision

Improving healthcare provision, increased incidence of chronic diseases, the appearance of safer drug delivery systems and medical tourism are driving pharmaceutical industries in emerging markets. Branded drugs penetration is about 25% (due to the importance of generic drugs) as compared to about 75% in developed economies, according to IMS, giving the potential for expansion in the branded sector. 

Pharmaceuticals companies should focus on these emerging markets. 


24/7 Customer Support

Talk to Sam

+44 208 068 8943

1-10 of about 41000 reports

Global Pharmaceutical Trade

  • July 2017
    8 pages
  • Pharmaceutical  

  • Europe  


    United Kingdom  

View report >

Pharmaceutical Markets in the US

  • August 2017
    9 pages
  • Pharmaceutical  

  • United States  

View report >

Pharmaceutical Industry in Europe and India - Forecast

  • July 2017
    11 pages
  • Pharmaceutical  


  • Europe  



View report >

Pharmaceutical Industry in India and Asia

  • March 2016
    79 pages
  • India  



View report >

Pharmaceutical Statistics in Japan and Australia

  • August 2017
    11 pages
  • Pharmaceutical  

  • Japan  


    South Korea  

View report >

Pharmaceutical Markets in France and Europe

  • October 2016
    20 pages
  • Pharmaceutical  

  • Europe  


View report >

The future of the Pharmaceutical Industry in Germany

  • January 2017
    16 pages
  • Pharmaceutical  

  • Germany  



View report >

Pharmaceutical Markets in Italy - Forecast

  • August 2017
    8 pages
  • Pharmaceutical  

  • Italy  

View report >

Pharmaceutical Industry in the UK

  • July 2017
    43 pages
  • Pharmaceutical  


  • United Kingdom  

View report >

Pharmaceutical Industry in Canada

  • July 2017
    41 pages
  • Pharmaceutical  

  • Canada  

View report >

About 12000 reports

Purchase Reports From Reputable Market Research Publishers
(From € 148 - € 68182)

Immunodiagnostics Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • € 68182
  • Industry report
  • July 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

Clinical Chemistry Reagents And Analyzers Market 2021: ...

May 2017 € 68182

Tumor Markers Testing Market 2021: A 74-country Analysi ...

June 2017 € 47636

Cancer Diagnostics Market 2021: A 74-country Analysis-- ...

May 2017 € 47636

Europe Immunodiagnostics Analyzers And Reagents Market ...

July 2017 € 34091

Europe Clinical Chemistry Reagents And Analyzers Market ...

May 2017 € 34091

Europe Tumor Markers Testing Market 2021: A 31-country ...

June 2017 € 32727

Europe Cancer Diagnostics Market 2021: A 31-country Ana ...

May 2017 € 32727

2017-2021 World Immunodiagnostics Market: Supplier Shar ...

July 2017 € 21364

Migraine Disease Coverage Forecast And Market Analysis

July 2017 € 20000

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.